Scaffold Hopping

The fundamental distinction lies in the molecular core—the central ring system or scaffold—versus peripheral substituents. Scaffold hopping replaces the central pharmacophoric anchor while retaining the relative spatial orientation of key interacting groups. This is not simple bioisosteric replacement of a single atom; it is a wholesale topological transformation of the molecular skeleton.

This approach defines a molecule by its abstract 3D pharmacophore—a set of steric and electronic features (hydrogen bond donors/acceptors, hydrophobic centroids, aromatic rings) essential for activity. The algorithm then searches a virtual library for compounds that match this spatial arrangement with a chemically distinct scaffold. Key steps include:

• Feature extraction from the active ligand
• Exclusion volume definition to avoid steric clashes
• Alignment-independent similarity scoring

Shape-based methods prioritize volumetric overlap over explicit chemical feature matching. The query molecule's molecular electrostatic potential and van der Waals surface are encoded as a Gaussian volume. The algorithm screens for molecules with high Tanimoto shape similarity but low Tanimoto fingerprint similarity, ensuring a novel scaffold that occupies the same binding pocket topography. Tools like ROCS (Rapid Overlay of Chemical Structures) exemplify this method.

This method operates on the molecular graph directly. The scaffold is extracted by pruning all terminal side chains, leaving only the Murcko framework—the ring systems and linkers connecting them. Hopping is achieved by enumerating alternative frameworks that preserve the attachment vectors (the exit bonds where side chains connect) in the correct geometry. This is often combined with matched molecular pair analysis to quantify the impact of the scaffold change on activity.

Rather than replacing the entire core at once, this strategy deconstructs the original scaffold into smaller fragment components. A computational algorithm then reconnects these fragments with alternative linkers or ring systems, or grows a new core from a key binding fragment. This is guided by binding free energy calculations to ensure the new scaffold maintains affinity. It is particularly useful when the original scaffold has a high degree of flexibility.

Modern deep learning models, particularly reinforcement learning agents and variational autoencoders, are trained to generate molecules conditioned on a 3D pharmacophore or shape query. The model's latent space is sampled to produce valid SMILES strings with high shape similarity but low scaffold similarity to the query. This moves beyond database searching into true de novo scaffold invention, often incorporating synthetic accessibility scores to ensure the output is makeable.

A fixed-length bit or count vector encoding the presence or absence of specific substructures, circular atom environments, or pharmacophoric features. Fingerprints are the primary numerical representation used to compute Tanimoto similarity between a query molecule and candidate scaffolds. Common implementations include ECFP4 (Extended Connectivity Fingerprints) and MACCS keys. In scaffold hopping, 2D fingerprint similarity often fails to capture bioisosteric equivalence, necessitating 3D shape-based fingerprints.

A widely used metric for quantifying the structural overlap between two molecules based on their molecular fingerprints, ranging from 0 (no overlap) to 1 (identical). Calculated as the ratio of intersecting bits to the union of bits. While a high Tanimoto score typically indicates scaffold conservation, scaffold hopping explicitly seeks molecules with low Tanimoto similarity (< 0.5) to the query but high 3D shape and electrostatic similarity.

The chemical principle underlying scaffold hopping. It involves substituting one functional group or core ring system with another that exhibits similar steric and electronic properties, thereby retaining biological activity. Computational scaffold hopping automates this by searching databases for non-obvious bioisosteres. Key examples include:

• Classical Bioisosteres: Carboxylate to tetrazole
• Non-classical Bioisosteres: Amide bond to 1,2,3-triazole
• Ring equivalents: Phenyl to thiophene

An abstraction of the essential 3D spatial arrangement of chemical features—hydrophobic regions, hydrogen bond donors/acceptors, and aromatic rings—required for target binding. Unlike 2D fingerprint methods, pharmacophore-based scaffold hopping aligns candidate cores to the query's feature map, ignoring atomic connectivity. This enables the identification of structurally diverse scaffolds that present identical interaction patterns to the protein binding site.

A ligand-based virtual screening technique that compares the molecular volume and electrostatic potential of a query molecule against a database of compounds. Algorithms like ROCS (Rapid Overlay of Chemical Structures) use Gaussian functions to represent molecular shape. Scaffold hopping workflows prioritize hits with high 3D shape overlap but low 2D fingerprint similarity, maximizing the chance of finding patent-busting cores that maintain the binding pose.

The systematic navigation of the vast theoretical universe of synthesizable molecules. Scaffold hopping is a directed search within this space, moving from a known active region to a distant, structurally novel region that shares biological activity. Techniques like generative models and virtual enumeration of enumerated compound libraries are used to populate these unexplored regions with viable, drug-like candidates for screening.